Community Partnership to Examine Racial and Ethnic Differences in Health Care for Hypertension and Diabetes

Hypertension Clinical Trial

— CHAMPP  

Official title:

Community, Health Center, and Academic Medicine Partnership Project (CHAMPP)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00379652
• Other study ID #: 410
• Secondary ID: R21HL083859-011R
• Status: Completed
• Phase: N/A
• Start date: October 2009
• Est. completion date: May 2010

Study information

• Verified date: January 2023
• Source: Harvard Medical School (HMS and HSDM)
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Hypertension and diabetes are among the most common chronic diseases in the United States. Racial and ethnic minority groups are more at risk for these diseases than the Caucasian population. This study will attempt to identify factors that contribute to racial and ethnic differences in hypertension and diabetes care among minority patients of community health centers (CHCs). This information will be used to design and implement programs to improve quality of care in these communities.

Description:

Hypertension and diabetes are the primary contributors to today's high rates of heart disease and stroke, which are the first and third leading causes of death in the United States, respectively. African Americans and Hispanics have a higher risk of developing hypertension and diabetes than do Caucasians. They are also less likely to know that they have high blood pressure, are more prone to organ damage, and are more likely to die as a result of these chronic conditions. A significant number of African Americans and Hispanics are uninsured and receive care through publicly supported CHCs. It is important to identify factors that contribute to healthcare differences among the lower income, uninsured, and minority populations that are typically served by CHCs. In this study, a collaborative partnership will be developed between CHCs, health service research organizations, and academic researchers. The goal of the study is to examine the barriers that minority CHC patients face in receiving appropriate hypertension and diabetes care.

This study will develop a collaborative partnership between various health organizations and seven CHCs located in Boston neighborhoods that have a large percentage of African American and Hispanic residents. Researchers will conduct focus groups with CHC patients who are receiving care for hypertension or diabetes. CHC staff members will be interviewed to collect information regarding the relationship between CHC organizational structure and disparities in heart disease risk factors among minority patients with hypertension or diabetes. Researchers will then develop, implement, and evaluate a patient- and CHC-focused intervention aimed at reducing the cardiovascular risks of minority patients at four CHCs in Boston.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1204
• Est. completion date: May 2010
• Est. primary completion date: May 2010
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Diabetes

• Hypertension, as diagnosed by the average of two or more blood pressure measurements taken during two or more study visits following an initial screening

• Race is 'Black' or ethnicity is 'Hispanic'

• Patient at participating Community Health Center

Related Conditions & MeSH terms

• Diabetes Mellitis
• Hypertension

Intervention

Behavioral:
• Medical Practice Improvement
The details for the medical practice improvement intervention will be decided at a later date.
• Patient Education and Support
The details for the patient education and support intervention will be decided at a later date.

Other:
• Combination Intervention to Include Medical Practice Improvement and Patient Education and Support
The details for this combination intervention will be decided at a later date.

Locations

Country	Name	City	State
United States	Center for Community Health Education, Research, and Service	Boston	Massachusetts
United States	Harvard Medical School	Boston	Massachusetts

Sponsors (2)

Lead Sponsor	Collaborator
Harvard Medical School (HMS and HSDM)	National Heart, Lung, and Blood Institute (NHLBI)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Potential outcomes for the future intervention include systolic blood pressure, diastolic blood pressure, and hemoglobin A1c		Measured from June to August 2008